SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending amid speculation surrounding a potential SpaceX IPO and renewed interest in space infrastructure. Community discussions highlight the possibility of sector re-ratings and potential contract awards, while also weighing valuation concerns. Some investors are taking profits while others see long-term potential.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is trending with community members highlighting its explosive momentum and resilience, particularly within the Ethereum ecosystem. Bullish sentiment is fueled by increased volume across multiple exchanges, and holders believe $YEE is carving out a strong position as the next big meme token.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as cannabis stocks react to speculation around potential federal policy changes, including the possibility of the Trump administration reclassifying marijuana, which could ease restrictions and provide tax benefits to cannabis companies. Community members are actively discussing potential entry points, trading strategies around options, and the possible impact on specific companies within the sector. Some caution against hype, noting previous false starts, while others express optimism for substantial gains if rescheduling occurs.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation and rumors surrounding potential marijuana rescheduling, with community members citing reports of a possible executive order from President Trump as soon as Monday. Discussions include the impact of rescheduling on the company, potential price targets, and the possibility of a short squeeze. The community's bullish sentiment is fueled by the potential for eased regulations and increased investment in the cannabis sector.

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Quincy, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve Cannabis ($TCNNF) is trending amid speculation around potential cannabis rescheduling and its impact on the industry, with community members discussing the possibility of gains and strategic positioning. Some investors believe that rescheduling is near, while others express skepticism due to past disappointments. The potential for federal policy changes and the stock's perceived undervaluation are key talking points.

Etsy, Inc. engages in the operation of an online marketplace. It offers handmade products such as shoes, clothing, bags, and accessories. It operates through the following segments: Etsy, Reverb, and Depop. The company was founded in 2005 and is headquartered in New York, NY.

Etsy Inc

Etsy is trending as traders discuss potential holiday season tailwinds and marketplace expansion. Bullish sentiment is fueled by actionable trade alerts and technical analysis pointing to constructive intraday structure. Community members are also weighing factors like the stock's valuation and potential impact from AI initiatives.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

401jK is trending as community members rally around its mission to redefine retirement and challenge traditional financial systems. Bullish sentiment is fueled by the project's strong community, new exchange listings, and the belief that it addresses widespread frustration with conventional 401(k) plans. The community is actively promoting the token's vision of financial freedom through memes and content creation.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

SNAP is trending as investors debate its future, with discussions around its AI partnership with Perplexity, potential for growth, and the impact of regulations like Australia's proposed social media ban for those under 16. Bullish arguments include undervaluation and potential for a turnaround, while bearish concerns focus on profitability, leadership, and the company's ability to compete.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is trending as the community discusses its volatile price action and potential connection to the broader AI sector following recent market fluctuations. Some traders are pointing to data center growth as a bullish catalyst, while others are wary of overvaluation and potential market manipulation. Discussions also include potential support levels and debate about whether the stock is a long-term hold.

Polestar Automotive Holding UK Plc is the Swedish electric performance car brand that engages in the research, development, marketing, commercialization, and sales of battery electric vehicles and related technology solutions. It offers Polestar 2 (PS2), a premium fast-back sedan, the Polestar 3 (PS3), a luxury aero sport-utility vehicle, the Polestar 4 (PS4), a premium sport utility vehicle, the Polestar 5 (PS5), a luxury sport grand-touring sedan, and the Polestar 6 (PS6), a luxury roadster. The company was founded on September 15, 2021 and is headquartered in Gothenburg, Sweden.

Polestar Automotive Holding UK PLC - ADR Class A

Polestar ($PSNY) is trending amid discussions of a potential reverse stock split and overall financial health, with some traders pointing out a possible short squeeze due to limited share availability and upcoming reporting this week. Despite some positive sentiment around sales numbers, the community is also discussing potential red flags on the balance sheet, high cash burn, and concerns about the stock's long-term viability within the competitive EV sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Average Rating of "Hold" from Brokerages

Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX - Get Free Report) have been given a consensus recommendation of "Hold" by the seven research firms that are presently covering the company...

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Crosses Above Two Hundred Day Moving Average - What's Next?

Lexicon Pharmaceuticals (NASDAQ:LXRX) Share Price Passes Above 200 Day Moving Average - Here's Why...

Leerink Partnrs Has Pessimistic View of LXRX FY2028 Earnings

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX - Free Report) - Equities researchers at Leerink Partnrs reduced their FY2028 earnings per share estimates for shares of Lexicon Pharmaceuticals in a...

Wall Street Zen Downgrades Lexicon Pharmaceuticals (NASDAQ:LXRX) to Hold

Wall Street Zen lowered shares of Lexicon Pharmaceuticals from a "buy" rating to a "hold" rating in a report on Saturday...

Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 11.6% Higher - Should You Buy?

Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading Up 11.6% - Here's Why...

What is HC Wainwright's Estimate for LXRX FY2025 Earnings?

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX - Free Report) - Research analysts at HC Wainwright upped their FY2025 earnings per share (EPS) estimates for shares of Lexicon Pharmaceuticals in a note...

Lexicon Pharmaceuticals (LXRX) Reports Q3 Loss, Beats Revenue Estimates

Lexicon (LXRX) delivered earnings and revenue surprises of +42.86% and +140.78%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Dianthus Therapeutics, Inc. (DNTH) Reports Q3 Loss, Lags Revenue Estimates

Dianthus Therapeutics, Inc. (DNTH) delivered earnings and revenue surprises of -12.79% and -39.63%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Lexicon (LXRX) Upgraded to Buy: Here's What You Should Know

Lexicon (LXRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Lexicon Pharmaceuticals (LXRX) Q2 Earnings and Revenues Top Estimates

Lexicon (LXRX) delivered earnings and revenue surprises of +112.50% and +344.78%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.

Current Price	$1.30
Prev Close	$1.32
Open	$1.32
Dividend Yield	0.00%
50-Day Moving Average	$1.42
Beta	1.68
Avg. Volume	2.23M
PE Ratio	-6.86

52-Week High	$1.66
52-Week Low	$0.2836
Market Capitalization	$481.7M
EPS (Annual)	-$0.6262
Price to Book	3.93
Revenue Per Employee	$301,757.28
Enterprise Value/EBITDA	N/A

LXRX
Lexicon Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LXRX News

LXRXLexicon Pharmaceuticals Inc